MultiPlan Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

$MPLN
Business Services
Consumer Discretionary
Get the next $MPLN alert in real time by email
mpln-20250217
0001793229FALSE--12-3100017932292025-02-172025-02-17

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 17, 2025

Claritev Corporation
(Exact name of registrant as specified in its charter)
Delaware001-3922884-3536151
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
115 Fifth Avenue
New York, New York 10003
(212) 780-2000
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)

MultiPlan Corporation
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)
Name of each exchange on which registered
Shares of Class A Common Stock,
$0.0001 par value per share
MPLNNew York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company




If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

On February 17, 2025, MultiPlan Corporation (the “Company”) changed its corporate name to Claritev Corporation pursuant to a certificate of amendment (the “Certificate of Amendment”) to its Second Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”) filed with the Delaware Secretary of State on February 17, 2025 (the “Name Change”). Pursuant to Delaware law, a shareholder vote was not necessary to effectuate the Name Change and it does not affect the rights of the Company’s shareholders. The Company also amended and restated its bylaws (the “Amended and Restated Bylaws”) effective February 17, 2025 to reflect the Name Change.

The Company also announced that it intends for its Class A common stock to cease trading under the ticker symbol “MPLN” and begin trading under its new ticker symbol, “CTEV”, on the New York Stock Exchange, which the Company expects to be effective on February 28, 2025.

Copies of the Certificate of Amendment and Amended and Restated Bylaws are filed as Exhibit 3.1 and Exhibit 3.2, respectively, with this Current Report on Form 8-K and are incorporated herein by reference. The only change to the Certificate of Incorporation and Amended and Restated Bylaws is the change of the Company’s corporate name from MultiPlan Corporation to Claritev Corporation in each document (or other related changes resulting from the name change, such as website address).


Item 7.01 Regulation FD Disclosure

On February 17, 2025, the Company issued a press release announcing the Name Change, a copy of which is furnished as Exhibit 99.1 and is incorporated herein by reference.

The information, including the press release, furnished under this Item 7.01 shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference into any other filing by the Company under the Exchange Act or the Securities Act of 1933, as amended, except as otherwise expressly stated in such filing.




Item 9.01    Financial Statements and Exhibits.
 (d) Exhibits
The following exhibits are included in this Form 8-K:



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated:    February 19, 2025



                                Claritev Corporation

                                By:    /s/ Douglas M. Garis         
                                Name:    Douglas M. Garis
                                Title:    Executive Vice President and Chief Financial Officer



Get the next $MPLN alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MPLN

DatePrice TargetRatingAnalyst
6/26/2024$2.00Neutral
Piper Sandler
12/13/2022$3.00 → $2.00Buy → Neutral
Citigroup
7/12/2022$6.50Neutral
Goldman
12/20/2021$9.00 → $7.00Buy
Citigroup
11/11/2021$7.00 → $6.00Equal-Weight
Barclays
10/4/2021$9.00Buy
Citigroup
8/20/2021$9.00Buy
Tigress Financial
More analyst ratings

$MPLN
Press Releases

Fastest customizable press release news feed in the world

See more
  • ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks

    Latest agreement expands access to the PHCS and MultiPlan Networks ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced an agreement with Claritev, Inc. ("Claritev") (NYSE:CTEV), previously MultiPlan, Inc. (NYSE:MPLN), a technology and data insights company focused on making healthcare more affordable, transparent, and fair for all. As part of the agreement, ClearNote Health's Avantect® Pancreatic Cancer Test will now be available to health plan members accessing Claritev's national PHCS and MultiPlan Networks. While early detection has vastly improved survival rates for many types of cancer, pancreatic cancer is often diagnos

    $CTEV
    $MPLN
    Business Services
    Consumer Discretionary
  • Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025

    Q4 2024 Revenues of $232.1 million, Net Loss of $138.0 million and Adjusted EBITDA of $141.6 million Full Year 2024 Revenues of $930.6 million, Net Loss of $1,645.8 million and Adjusted EBITDA of $576.7 million Full Year 2025 Revenues guidance of (2)% to flat as compared to FY 2024 and FY 2025 Adjusted EBITDA % guidance of 62.5% to 63.5% Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the fourth quarter and full year ended December 31, 2024. Chairman, CEO and President Travis Dalt

    $MPLN
    Business Services
    Consumer Discretionary
  • Claritev Provides Oracle Cloud HCM Customers with Actionable Insights for Healthcare Cost Optimization and Plan Design

    Claritev's Award-Winning Analytics Solution, BenInsights®, is Powered by Oracle Cloud and Now Available in the Oracle Cloud Marketplace Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, and an Oracle partner, announced today its analytics solution, BenInsights®, has achieved Integrated with Oracle Cloud Expertise and is now available in the Oracle Cloud Marketplace, offering added value to Oracle Cloud customers. The BenInsights platform enables visibility into benefit plan performance and compliance responsibilities for employers of

    $MPLN
    Business Services
    Consumer Discretionary

$MPLN
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$MPLN
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$MPLN
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$MPLN
SEC Filings

See more

$MPLN
Leadership Updates

Live Leadership Updates

See more
  • MultiPlan Appoints Tiffani Misencik to Drive Strategic Growth

    Tiffani Misencik Named Chief Growth Officer in New Executive Leadership Role MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced a new addition to its executive leadership team to support the next phase of the Company's strategic growth. Tiffani Misencik has been appointed Chief Growth Officer. In this newly created role, Misencik will oversee MultiPlan's sales and revenue growth strategy across all market segments. She will lead the company's efforts in client acquisition, client management, an

    $MPLN
    Business Services
    Consumer Discretionary
  • MultiPlan Makes Fortune's Best Workplaces in Health Care List for Second Year in a Row

    MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, is honored to announce it has been named in the 2024 Fortune Best Workplaces in Health Care™ List. based on its 2023-2024 Great Place to Work® Certification™ results. This is the second time MultiPlan has been named in the Best Workplaces in Health Care list. Earning a spot means that MultiPlan is one of the best companies to work for in the country. The Best Workplaces in Health Care list is based on analysis of survey responses from over 185,000 employees from Great Place To Work Cer

    $MPLN
    Business Services
    Consumer Discretionary
  • MultiPlan Announces CFO Transition

    MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the

    $DOOR
    $MPLN
    $ORCL
    $CERN
    Forest Products
    Basic Materials
    Business Services
    Consumer Discretionary

$MPLN
Financials

Live finance-specific insights

See more
  • Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025

    Q4 2024 Revenues of $232.1 million, Net Loss of $138.0 million and Adjusted EBITDA of $141.6 million Full Year 2024 Revenues of $930.6 million, Net Loss of $1,645.8 million and Adjusted EBITDA of $576.7 million Full Year 2025 Revenues guidance of (2)% to flat as compared to FY 2024 and FY 2025 Adjusted EBITDA % guidance of 62.5% to 63.5% Claritev Corporation ("Claritev" or the "Company") (NYSE:MPLN), formerly known as MultiPlan, a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the fourth quarter and full year ended December 31, 2024. Chairman, CEO and President Travis Dalt

    $MPLN
    Business Services
    Consumer Discretionary
  • MultiPlan Corporation Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

    MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of technology and data solutions that improve affordability, quality and transparency in healthcare, announced today that it will release its fourth quarter and full year 2024 financial results on Tuesday, February 25, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique pin. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to: https://www.netroadsho

    $MPLN
    Business Services
    Consumer Discretionary
  • MultiPlan Reports Third Quarter 2024 Results and Updates 2024 Guidance

    – Q3 2024 Revenues of $230.5 million, Net Loss of $391.5 million (including a $361.6 million impairment of goodwill and indefinite-lived intangibles), and Adjusted EBITDA of $141.6 million – Identified potential medical cost savings of approximately $6.4 billion in Q3 2024, up 10% from Q3 2023 and up 3% from Q2 2024 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton said,

    $MPLN
    Business Services
    Consumer Discretionary

$MPLN
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more